NCT04152759 - Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects | Biotech Hunter

Enrollment

182

Participants

Timeline

Start Date

September 9, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Psoriatic Arthritis

Interventions

DRUG

Drug: BAT2506 injection Other Names: Simponi(EU-licensed)

"Drug: BAT2506 injection Each subject will receive single subcutaneous injection of 50 mg BAT2506 Injection or Simponi(EU-licensed).~Other Names:~Simponi(EU-licensed)"

Trial Locations (1)

Unknown

The First Bethune Hospital of Jilin University, Changchun